Menu
Cart 0
Celiac Disease Treatment Market

Celiac Disease Treatment Market - Forecasts from 2016 to 2021

  • $3,200.00
  • Publishing Date: October 2016
  • Format: PDF
Sample Request

Celiac disease is a digestive disorder that makes it difficult for the body to absorb nutrients like fat, calcium, iron and folate. It is an autoimmune disease in which lining of the small intestine is damaged when foods with gluten are eaten. This disease is genetic in nature and is common among people suffering from type 1 diabetes, Down syndrome, autoimmune thyroid disease, microscopic colitis, Addison’s disease and rheumatoid arthritis. The market for celiac disease treatment is expected to witness significant growth in the years ahead, driven by various anti-inflammatory drugs and therapeutic vaccines in the pipeline that are to replace or supplement a gluten-free diet. Rising healthcare expenditure, growing medical research, greater awareness about the disease is expected to further bolster this growth. Geographically, Europe and North America are the largest treatment markets for Celiac disease, owing to the high prevalence and a well-established healthcare landscape. Africa on the other hand is a market with great potential, given the fact that highest prevalence of the disease is found in the Saharawi people of Africa.

Research Methodology

This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.

Industry Overview

In this section, the entire Celiac disease market is explained along with the causes, diagnosis and prevention of the disease, the various drivers, restraints and opportunities to its treatment market and the prevalence of the disease based on age, gender and region. A product pipeline of various drugs and vaccines for celiac disease therapy have been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.

Segmentation

Celiac disease treatment market has been segmented based on the type of drug and geography as below:

  • By Type
    • Vitamins and Dietary Supplements
    • Steroids and Immunosuppressive Drugs
    • Therapeutic Vaccines
  • By Geography
    • Americas
      • North America
      • South America
    • Europe Middle East and Africa
      • Europe
      • Middle East and Africa
    • Asia Pacific

Market Players

This Section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players in celiac disease treatment market are BioLineRx, Calimmune, ImmusanT, ImmunogenX, and Innovate Biopharmaceuticals among others.

1. Introduction
2. Research Methodology
3. Executive Summary
4. Celiac Disease Treatment Industry Overview
4.1. Market Overview
4.2. Drivers, Restraints, and Opportunities
4.3. Industry Value Chain Analysis
4.4. Prevalence
4.4.1. By Age Group
4.4.2. By Gender
4.4.3. By Region
4.5. Product Pipeline
4.6. Innovations
4.7. Industry Regulations
4.8. Scenario Analysis
5. Celiac Disease Treatment Market Forecast by Type (US$ million)
5.1. Vitamins and Dietary Supplements
5.2. Steroids and Immunosuppressive Drugs
5.3. Therapeutic Vaccines
6. Celiac Disease Treatment Market Forecast by Geography (US$ million)
6.1. Americas
6.1.1. North America
6.1.2. South America
6.2. Europe Middle East and Africa
6.2.1. Europe
6.2.2. Middle East and Africa
6.3. Asia Pacific
7. Competitive Intelligence
7.1. Market Share Analysis
7.2. Investment Analysis
7.3. Recent Deals
7.4. Strategies of Key Players
8. Company Profiles
8.1. BioLineRx
8.2. Calimmune
8.3. ImmusanT
8.4. ImmunogenX
8.5. Innovate Biopharmaceuticals
8.6. Alba Therapeutics
8.7. Alvine Pharmaceuticals
8.8. Calypso Biotech
8.9. Cour Pharmaceuticals
8.10. Doctor Falk Pharmaceuticals

Related Reports
Back to the top